 |
SalubrisBio
Last updated: September 17, 2025
Sam Murphy, CEO
USA | Funding: $102M (+)
Website: https://www.salubrisbio.com
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Website: https://www.salubrisbio.com
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
